Universität zu Köln

Journal Article

Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Dafni, Urania, Wolf, Juergen, Wasag, Bartosz ORCID: 0000-0002-3634-7562, Biernat, Wojciech, Finn, Stephen P., Kammler, Roswitha, Tsourti, Zoi, Rabaglio, Manuela, Ruepp, Barbara, Roschitzki-Voser, Heidi, Stahel, Rolf A., Felip, Enriqueta and Peters, Solange (2019). Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP). J. Thorac. Oncol., 14 (6). S. 1086 - 1095. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Fassunke, Jana, Mueller, Fabienne, Keul, Marina, Michels, Sebastian, Dammert, Marcel A., Schmitt, Anna, Plenker, Dennis, Lategahn, Jonas ORCID: 0000-0001-5993-7082, Heydt, Carina, Braegelmann, Johannes, Tumbrink, Hannah L., Alber, Yannic, Klein, Sebastian, Heimsoeth, Alena, Dahmen, Ilona, Fischers, Rieke N., Scheffler, Matthias, Ihle, Michaela A., Priesner, Vanessa, Scheel, Andreas H., Wagener, Svenja, Kron, Anna, Frank, Konrad, Garbert, Katia, Persigehl, Thorsten, Puesken, Michael, Haneder, Stefan, Schaaf, Bernhard, Rodermann, Ernst, Engel-Riedel, Walburga, Felip, Enriqueta, Smit, Egbert F., Merkelbach-Bruse, Sabine, Reinhardt, H. Christian, Kast, Stefan M., Wolf, Juergen, Rauh, Daniel, Buettner, Reinhard and Sos, Martin L. (2018). Overcoming EGFR(G724S)-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors. Nat. Commun., 9. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Felip, Enriqueta, Smit, Egbert F., Molina-Vila, Miguel A., Dafni, Urania, Massuti, Bartomeu, Berghmans, Thierry, de Marinis, Filippo, Passiglia, Francesco, Dingemans, Anne-Marie C., Cobo, Manuel, Viteri, Santiago ORCID: 0000-0002-7572-1123, Britschgi, Christian ORCID: 0000-0001-8831-1564, Cuffe, Sinead, Provencio, Mariano ORCID: 0000-0001-9053-9197, Merkelbach-Bruse, Sabine, Andriakopoulou, Charitini, Kammler, Roswitha, Ruepp, Barbara, Roschitzki-Voser, Heidi, Peters, Solange, Wolf, Juergen and Stahel, Rolf (2022). Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial. Lung Cancer, 172. S. 94 - 100. CLARE: ELSEVIER IRELAND LTD. ISSN 1872-8332

Gautschi, Oliver, Milia, Julie, Cabarrou, Bastien, Bluthgen, Marie-Virginia, Besse, Benjamin ORCID: 0000-0001-5090-8189, Smit, Egbert F., Wolf, Juergen, Peters, Solange, Frueh, Martin, Koeberle, Dieter, Oulkhouir, Youssouf, Schuler, Martin, Curioni-Fontecedro, Alessandra, Huret, Benjamin, Kerjouan, Mallorie, Michels, Sebastian, Pall, Georg, Rothschild, Sacha ORCID: 0000-0003-1304-9340, Schmid-Bindert, Gerald, Scheffler, Matthias ORCID: 0000-0002-9031-1368, Veillon, Remi, Wannesson, Luciano, Diebold, Joachim, Zalcman, Gerard, Filleron, Thomas and Mazieres, Julien (2015). Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort. J. Thorac. Oncol., 10 (10). S. 1451 - 1458. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Groen, Harry J. M., Akerley, Wallace L., Souquet, Pierre Jean, Laack, Eckart, Han, Ji-Youn, Smit, Egbert F., Mansfield, Aaron Scott, Garon, Edward B., Wolf, Juergen, Tan, Daniel Shao-Weng, Heist, Rebecca Suk, Waldron-Lynch, Maeve, Le Mouhaer, Sylvie, Nwana, Ngozi, Giovannini, Monica and Orlov, Sergey (2020). Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small-cell lung cancer (NSCLC): results from cohort 6 of the phase 2 GEOMETRY mono-1 study. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Heist, Rebecca Suk, Garon, Edward B., Tan, Daniel Shao-Weng, Groen, Harry J. M., Seto, Takashi, Smit, Egbert F., Zou, Mike R., Yang, Yiqun, Li, Ying, Chassot-Agostinho, Andrea and Wolf, Juergen (2021). Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay: Results from the GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Kim, Dong-Wan, Tan, Daniel Shao-Weng, Aix, Santiago Ponce, Sequist, Lecia V., Smit, Egbert F., Hida, Toyoaki, Yang, James Chih-Hsin, Felip, Enriqueta, Seto, Takashi, Grohe, Christian, Wolf, Juergen, Ko, Jinnie, Diallo, Mariama, Pultar, Philippe, Giovannini, Monica and Kim, Sang-We (2018). Preliminary Phase II results of a multicenter, open-label study of nazartinib (EGF816) in adult patients with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC). J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Mazieres, Julien, Zalcman, Gerard, Crino, Lucio, Biondani, Pamela, Barlesi, Fabrice, Filleron, Thomas, Dingemans, Anne-Marie C., Lena, Herve, Monnet, Isabelle, Rothschild, Sacha I., Cappuzzo, Federico, Besse, Benjamin ORCID: 0000-0001-5090-8189, Thiberville, Luc, Rouviere, Damien, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Wolf, Jurgen, Spirig, Christian, Pecuchet, Nicolas ORCID: 0000-0002-3321-5791, Leenders, Frauke, Heuckmann, Johannes M., Diebold, Joachim, Milia, Julie D., Thomas, Roman K. and Gautschi, Oliver (2015). Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. J. Clin. Oncol., 33 (9). S. 992 - 1002. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Mazieres, Julien, Zalcman, Gerard, Crino, Lucio, Biondani, Pamela, Barlesi, Fabrice, Filleron, Thomas, Dingemans, Anne-Marie C., Lena, Herve, Monnet, Isabelle, Rothschild, Sacha I., Cappuzzo, Federico, Besse, Benjamin ORCID: 0000-0001-5090-8189, Thiberville, Luc, Rouviere, Damien, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Wolf, Jurgen, Spirig, Christian, Pecuchet, Nicolas ORCID: 0000-0002-3321-5791, Leenders, Frauke, Heuckmann, Johannes M., Diebold, Joachim, Milia, Julie D., Thomas, Roman K. and Gautschi, Oliver (2015). Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. J. Clin. Oncol., 33 (9). S. 992 - 1002. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Mazieres, Julien, Zalcman, Gerard, Crino, Lucio, Biondani, Pamela, Besse, Benjamin ORCID: 0000-0001-5090-8189, Dingemans, Anne-Marie C., Lena, Herve, Monnet, Isabelle, Rothschild, Sacha ORCID: 0000-0003-1304-9340, Cappuzzo, Federico, Thiberville, Luc, Rouviere, Damien, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Wolf, Juergen, Spirig, Christian, Pecuchet, Nicolas, Diebold, Joachim, Milia, Julie and Gautschi, Oliver (2014). Efficacy of crizotinib in ROSI-rearranged lung cancer: The European experience. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Michels, Sebastian, Heydt, Carina, van Veggel, Bianca, Deschler-Baier, Barbara, Pardo, Nuria, Monkhorst, Kim, Ruesseler, Vanessa, Stratmann, Jan, Griesinger, Frank, Steinhauser, Susanne, Kostenko, Anna, Diebold, Joachim, Fassunke, Jana, Fischer, Rieke, Engel-Riedel, Walburga, Gautschi, Oliver, Geissinger, Eva, Haneder, Stefan, Ihle, Michaela A., Kopp, Hans-Georg, de Langen, Adrianus J., Martinez-Marti, Alex, Nogova, Lucia, Persigehl, Thorsten, Plenker, Dennis, Puesken, Michael, Rodermann, Ernst, Rosenwald, Andreas, Scheel, Andreas H., Scheffler, Matthias, Spengler, Werner, Seggewiss-Bernhardt, Ruth, Braegelmann, Johannes, Sebastian, Martin, Vrugt, Bart, Hellmich, Martin, Sos, Martin L., Heukamp, Lukas C., Felip, Enriqueta, Merkelbach-Bruse, Sabine, Smit, Egbert F., Buettner, Reinhard and Wolf, Juergen (2019). Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer. JCO Precis. Oncol., 3. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 2473-4284

Michels, Sebastian, Massuti, Bartomeu, Schildhaus, Hans-Ulrich, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Sebastian, Martin, Felip, Enriqueta, Grohe, Christian, Rodriguez-Abreu, Delvys, Abdulla, Diana S. Y., Bischoff, Helge, Brandts, Christian, Carcereny, Enric, Corral, Jesus, Dingemans, Anne-Marie C., Pereira, Eva, Fassunke, Jana, Fischer, Rieke N., Gardizi, Masyar, Heukamp, Lukas ORCID: 0000-0002-3388-3482, Insa, Amelia, Kron, Anna, Menon, Roopika, Persigehl, Thorsten, Reck, Martin, Riedel, Richard, Rothschild, Sacha I., Scheel, Andreas H., Scheffler, Matthias, Schmalz, Petra, Smit, Egbert F., Limburg, Meike, Provencio, Mariano, Karachaliou, Niki, Merkelbach-Bruse, Sabine, Hellmich, Martin, Nogova, Lucia, Buettner, Reinhard, Rosell, Rafael and Wolf, Juergen (2019). Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial. J. Thorac. Oncol., 14 (7). S. 1266 - 1277. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Smit, Egbert F., Peters, Solange, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Dafni, Urania, Wolf, Juergen, Wasag, Bartosz ORCID: 0000-0002-3634-7562, Biernat, Wojciech, Finn, Stephen, Kammler, Rosita, Tsourti, Zoi, Rabaglio-Poretti, Manuela, Ruepp, Barbara Ursula, Roschitzki-Voser, Heidi, Stahel, Rolf A. and Felip, Enriqueta (2017). A single-arm phase II trial of afatinib in pretreated patients with advanced NSCLC harboring a HER2 mutation: The ETOP NICHE trial. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Tan, Daniel S. W., Kim, Sang-We, Aix, Santiago Ponce, Sequist, Lecia, V, Smit, Egbert F., Yang, James C. H., Hida, Toyoaki, Toyozawa, Ryo, Felip, Enriqueta, Wolf, Juergen, Grohe, Christian, Leighl, Natasha B., Riely, Gregory, Cui, Xiaoming, Zou, Mike, Ghebremariam, Samson, O'Sullivan-Djentuh, Leslie, Belli, Riccardo, Giovannini, Monica and Kim, Dong-Wan (2022). Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: Results of a phase 2, single-arm, open-label study. Eur. J. Cancer, 172. S. 276 - 287. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Tan, Daniel Shao-Weng, Leighl, Natasha B., Yang, James Chih-Hsin, Riely, Gregory J., Sequist, Lecia, V, Toyozawa, Ryo, Wolf, Juergen, Felip, Enriqueta, Kim, Sang-We, Aix, Santiago Ponce, Smit, Egbert F., Hida, Toyoaki, Grohe, Christian, Ghebremariam, Samson, O'Sullivan-Djentuh, Leslie, Belli, Riccardo, Giovannini, Monica and Kim, Dong-Wan (2020). Nazartinib (EGF816) in patients with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC): Updated phase II results. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Wolf, Juergen, Overbeck, Tobias R., Han, Ji-Youn, Hochmair, Maximilian, de Marinis, Filippo, Ohashi, Kadoaki, Smit, Egbert F., Power, Danielle, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Waldron-Lynch, Maeve, Le Mouhaer, Sylvie, Nwana, Ngozi, Giovannini, Monica and Heist, Rebecca Suk (2020). Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Wolf, Juergen, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B., Groen, Harry J. M., Tan, Daniel S. W., Hida, Toyoaki, de Jonge, Maja, Orlov, Sergey V., Smit, Egbert F., Souquet, Pierre-Jean, Vansteenkiste, Johan, Hochmair, Maximilian, Felip, Enriqueta, Nishio, Makoto, Thomas, Michael, Ohashi, Kadoaki, Toyozawa, Ryo, Overbeck, Tobias R., de Marinis, Filippo, Kim, Tae-Min, Laack, Eckart, Robeva, Anna, Le Mouhaer, Sylvie, Waldron-Lynch, Maeve, Sankaran, Banu, Balbin, O. Alejandro, Cui, Xiaoming, Giovannini, Monica, Akimov, Mikhail and Heist, Rebecca S. (2020). Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. N. Engl. J. Med., 383 (10). S. 944 - 958. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406